Novel constructs and vectors for the targeted and inducible expression of genes

The invention concerns novel constructs and novel vectors for the targeted and inducible expression of genes. It describes in particular novel hybrid promoters and their use for the expression of genes in hepatic cells, in vitro, ex vivo or in vivo


Year:
2002
Note:
Applicant(s): Aventis Pharma S.A.
Other identifiers:
EPO Family ID: 9497481
Laboratories:




 Record created 2009-04-21, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)